Journal Articles Published by Division of TB Elimination (DTBE) Authors
2012 DTBE journal articles
Abraham BK, Winston CA, Magee E, Miramontes R. Tuberculosis among Africans living in the United States, 2000-2009. J Immigr Minor Health 2012 Apr 26.
Alexy ER, Podewils LJ, Mitnick CD, Becerra MC, Laserson KF, Bonilla C. Concordance of programmatic and laboratory-based multidrug-resistant tuberculosis treatment outcomes in Peru. Int J Tuberc Lung Dis 2012 March 1; 16 (3): 364-369.
Althomsons SP, Cegielski JP. Impact of second-line drug resistance on tuberculosis treatment outcomes in the United States: MDR-TB is bad enough. Int J Tuberc Lung Dis 2 August 2012 (e-publication ahead of print). http://dx.doi.org/10.5588/ijtld.11.0812.
Angra PK, Taylor TH, Iademarco MF, Metchock B, Astles, JR and Ridderhof JC. Performance of tuberculosis drug susceptibility testing in the United States laboratories from 1994–2008. J Clin Microbiol2012; 50(4):1233-39. DOI: 10.1128/JCM.06479-11.
Barry PM, Gardner TJ, Funk E, Oren E, Field K, Shaw T, et al. Multistate outbreak of MDR TB identified by genotype cluster investigation. Emerg Infect Dis [serial on the Internet]. 2012 Jan; available at http://dx.doi.org/10.3201/eid1801.110671
Bliven-Sizemore EE, Johnson JL, Goldberg S, Burman WJ, Villarino ME, Chaisson RE, for the TB Trials Consortium. Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment. Int J Tuberc Lung Dis 2012 Feb 8 [Online e-pub].
Bloss E, Chan P-C, Cheng N-W, Wang K-F, Yang S-L, Cegielski P. Increasing directly observed therapy related to improved tuberculosis treatment outcomes in Taiwan. Int J Tuberc Lung Dis 2012; 16(4):462–467; http://dx.doi.org/10.5588/ijtld.11.0121
Bloss E, Makombe R, Kip E, Smit M, Chirenda J, Gammino VM, Creek T, Oeltmann JE. Lessons learned during tuberculosis screening in public medical clinics in Francistown, Botswana. [Notes from the field.] Int J Tuberc Lung Dis 2012; e-publication ahead of print June 6, 2012; http://dx.doi.org/10.5588/ijtld.11.0736.
Cain KP, Garman KN, Laserson KF, Ferrousier-Davis OP, Miranda AG, Wells CD and Haley CA. Moving toward tuberculosis elimination implementation of statewide targeted tuberculin testing in Tennessee. Am J Respir Crit Care Med 2012 Aug 1; 186 (3): 273-279.
Cain KP, Varma JK. Finding tuberculosis at the first encounter with HIV care: don't miss the opportunity to save a life. Int J Tuberc Lung Dis 2012 Sep;16(9):1138.
Cavanaugh JS, Kazennyy BY, Nguyen ML, Kiryanova EV, Vitek E, Khorosheva TM, Nemtsova E, Cegielski JP. Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002–2005. Int J Tuberc Lung Dis 2012; e-publication ahead of print June 11, 2012; http://dx.doi.org/10.5588/ijtld.11.0696.
Cavanaugh JS, Powell K, Renwick OJ, Davis KL, Hilliard A, Benjamin C, Mitruka K. An outbreak of tuberculosis among adults with mental illness. Am J Psychiatry. 2012 Jun 1;169(6):569-75.Chen MP, Shang N, Winston CA, Becerra JE. A Bayesian analysis of the 2009 decline in tuberculosis morbidity in the United States. Statistics in Medicine 2012 March 13 [Online e-pub]. DOI: 10.1002/sim.5340.
Cegielski JP, Arab L, and Cornoni-Huntley J. Nutritional risk factors for tuberculosis among adults in the United States, 1971–1992. Am J Epidemiol 2012 [epub ahead of print]; DOI: 10.1093/aje/kws007.
Chen MP, Shang N, Winston CA, Becerra JE. A Bayesian analysis of the 2009 decline in tuberculosis morbidity in the United States. Statistics in Medicine 2012 March 13 [Online e-pub]. DOI: 10.1002/sim.5340.
Chigutsa E, Meredith S, Wiesner L, Padayatchi N, Harding J, Moodley P, Mac Kenzie WR, Weiner M, McIlleron H*, Kirkpatrick CMJ. Population Pharmacokinetics and Pharmacodynamics of Ofloxacin in South African Patients With Multi-Drug Resistant Tuberculosis. Antimicrob Agents Chemother 2012 May 7. [Epub ahead of print.]
Click ES, Feleke B, Pevzner E, Fantu R, Gadisa T, Assefa D, Melaku Z, Cain K, Menzies H. Evaluation of integrated registers for tuberculosis and HIV surveillance in children, Ethiopia, 2007-2009. Int J Tuberc Lung Dis 2012 Mar 12. [Online e-pub.]
Click ES, Moonan PK, Winston CA, Cowan LS, Oeltmann JE. Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis. CID 2012; 54 (2): 211-9.
Dharmadhikari AS, Mphahlele M, Stoltz A, Venter K, Mathebula R, Masotla T, Lubbe W, Pagano M, First M, Jensen PA, van der Walt M, Nardell EA. Surgical face masks worn by multidrug-resistant tuberculosis patients: impact on infectivity of air on a hospital ward. Am J Respir Crit Care Med 2012 Feb 9.
Dorman SE, Goldberg S, Stout JE, Muzanyi G, Johnson JL, Weiner M, Bozeman L, Heilig CL, Feng P-J, Moro R, Narita M, Nahid P, Ray S, Bates E, Haile B, Nuermberger EL, Vernon A, Schluger NW and the Tuberculosis Trials Consortium. Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the Tuberculosis Trials Consortium. J Infect Dis 2012 Jul 31; doi: 10.1093/infdis/jis461. [Epub ahead of print.]
Finlay A, Lancaster J, Holtz TH, Weyer K, Miranda A, van der Walt M. Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study. BMC Public Health 2012; 12:56; doi:10.1186/1471-2458-12-56. Available at http://www.biomedcentral.com/1471-2458/12/56.
Gler MT, Podewils LJ, Munez N, Galipot M, Quelapio MID, Tupasi TE. Impact of patient and program factors on default during treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2012 May 7 (e-pub ahead of print); available at http://dx.doi.org/10.5588/ijtld.11.0502.
Graham SG, Ahmed T, Amanullah F, Browning R, Cardenas V, Casenghi M, Cuevas LE, Gale M, Gie RP, Grzemska M, Handelsman E, Hatherill M, Hesseling AC, Jean-Philippe P, Kampmann B, Kabra SK, Lienhardt C, Lighter-Fisher J, Madhi S, Makhene M, Marais BJ, McNeeley DF, Menzies H, Mitchell C, Modi S, Mofenson L, Musoke P, Nachman S, Powell C, Rigaud M, Rouzier V, Starke JR, Swaminathan S, Wingfield C. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. JID 2012; published online March 22, 2012; doi: 10.1093/infdis/jis008.
Hill AN, Becerra JE, Castro KG. Modelling tuberculosis trends in the USA. Epidemiology and Infection 2012. Published online Jan. 11, 2012; doi:10.1017/S095026881100286X.
Jereb JA, Privett TD, Pearson ML. Tuberculin skin test conversions in hospital housekeepers. [Correspondence.] Int J Tuberc Lung Dis 2012 Feb 1; 16 (2): 279.
Kalokhe AS, Shafiq M, Lee JC, Metchock B, Posey JE, Ray SM, Anderson A, Wang YF, Nguyen ML. Discordance in Mycobacterium tuberculosis rifampin susceptibility. [Letter.] Emerg Infect Dis 2012; 18: (3): 537-9. Online: http://dx.doi.org/10.3201/eid1803.111357; DOI: 10.3201/eid1803.111357.
Kittikraisak W, Kingkaew P, Teerawattananon Y, Yothasamut J, Natesuwan S, Manosuthi W, Chongsuvivatwong V, Whitehead SJ. Health-related quality of life among patients with tuberculosis and HIV in Thailand. PLoS ONE 2012; 7(1): e29775. Epub 2012 Jan 11; doi:10.1371/journal.pone.0029775.
Kurbatova EV, Cavanaugh JS, Shah NS, Wright A, Kim H, Metchock B, Van Deun A, Barrera L, Boulahbal F, Richter E, Martín-Casabona N, Arias F, Zemanova I, Drobniewski F, Santos Silva A, Coulter C, Lumb R, Cegielski JP. Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs. [Short communication.] Int J Tuberc Lung Dis 2012 March; 16(3): 355–357.
Lamunu D, Chapman KN, Nsubuga P, Muzanyi G, Mulumba Y, Mugerwa MA, Goldberg S, Bozeman L, Engle M, Saukkonen J, Mastranunzio S, Mayanja-Kizza H, Johnson JL. Reasons for non-participation in an international multicenter trial of a new drug for tuberculosis treatment. Int J Tuberc Lung Dis 2012 April; 16(4):480–485; available at http://dx.doi.org/10.5588/ijtld.11.0434
LoBue PA, Castro KG. Is it time to replace the tuberculin skin test with a blood test? JAMA 2012;308:241-2.
Malik S, Willby M, Sikes D, Tsodikov OV, Posey JE (2012) New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations. PLoS ONE 7(6): e39754. doi:10.1371/journal.pone.0039754
Miramontes R, Winston CA, Haddad MB, Moonan PK. Use of tuberculosis genotyping
for postoutbreak monitoring. J Public Health Manag Pract 2012 Jul;18(4):375-8.
Mitruka K, Winston CA, Navin TR. Predictors of failure in timely tuberculosis treatment completion, United States. IJTLD 2012 June 5 (epub ahead of publication)
Moonan PK, Ghosh S, Oeltmann JE, Kammerer JS, Cowan LS, Navin TR. Using genotyping and geospatial scanning to estimate recent Mycobacterium tuberculosis transmission, United States. Emerg Infect Dis 2012 Mar; 18 (3): 458-465. Online at http://dx.doi.org/10.3201/eid1803.111107.
Olson NA, Davidow AL, Winston CA, Chen MP, Gazmararian JA, Katz DA. A national study of socioeconomic status and tuberculosis rates by country of birth, United States, 1996–2005. BMC Public Health 2012, 12:365 (e-publication).
Phanuphak N, Varma JK, Kittikraisak W, Teeratakulpisarn N, Phasitlimakul S, Suwanmala P, Pankam T, Burapat T, Tasaneeyapan T, McCarthy KD, Cain KP, Phanuphak P. Using tuberculin skin test as an entry point to screen for latent and active tuberculosis in Thai people living with HIV. J Acquir Immune Defic Syndr 2012 Apr 23.
Powell K, Lamb MM, Sisk MK, Federline L, Seechuk K, Lambert LA, Buff AM. Passenger contact investigation associated with a transport driver with pulmonary tuberculosis. Public Health Rep 2012;127(2):202-7.
Saukkonen JJ, Powell K, Jereb JA. Monitoring for tuberculosis drug hepatotoxicity: moving from opinion to evidence. [Editorial.] Am J Respir Crit Care Med 2012 Mar 15; 185(6): 598-9.
Schito ML, Peter TF, Cavanaugh S, Piatek AS, Young GJ, Alexander H, Coggin W, Domingo GJ, Ellenberger D, Ermantraut E, Jani IV, Katamba A, Palamountain KM, Essajee S, Dowdy DW. Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. J Infect Dis 2012 Apr 3. [Epub ahead of print.]
Shah NS, Cavanaugh JS, Pratt R, Cain KP, Wells C, Laserson K, Nelson L, Smith SE. Epidemiology of smear-negative pulmonary tuberculosis in the United States, 1993–2008. Int J Tuberc Lung Dis 2012; 16(9):1234–1240; e-pub ahead of print June 28, 2012. http://dx.doi.org/10.5588/ijtld.11.0794.
Smith SE, Kurbatova EV, Cavanaugh JS, Cegielski JP. Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis. [Short communication.] Int J Tuberc Lung Dis 2012 Feb 1; 16 (2): 203-205.
Stier DD, Thombley ML, Kohn MA, Jesada RA. The status of legal authority for injury prevention practice in state health departments. Am J Public Health 2012 Apr 19.
Tyrrell FC, Budnick GE, Elliott T, Gillim-Ross L, Hildred MV, Mahlmeister P, Parrish N, Pentella M, Vanneste J, Wang YF, Starks AM. Probability of negative Mycobacterium tuberculosis complex cultures based on time-to-detection of positive cultures: a multi-center evaluation of commercial broth-based culture systems. J Clin Microbiol. 2012 Jul 25. [Epub ahead of print]
Vernon AA and Villarino ME. Reinfection redux. [Editorial commentary.] Clin Infect Dis 2012 Mar 15; 54:792-793. Published online Jan. 19, 2012; doi:10.1093/cid/cir947.
Willis MD, Winston CA, Heilig CM, Cain KP, et al. Seasonality of tuberculosis in the United States, 1993-2008. Clin Infect Dis 2012 April 3; epub ahead of print: www.amedeo.com/p2.php?id=22474225&s=tb&pm=3e980a6a69d6756.
Winston CA, Hill AN, Chen MP, Shang N, Becerra JE. Confidence intervals and statistical testing for ratio measures of percent change. [Online e-pub.] Statistics in Medicine 2012 March 22. DOI: 10.1002/sim.5340.
Winston CA, Mitruka K. Treatment duration for patients with drug-resistant tuberculosis, United States [letter]. Emerg Infect Dis [serial on the Internet]. 2012 June. Available at http://dx.doi.org/10.3201/eid1807.120261
- Page last reviewed: August 14, 2012
- Page last updated: August 14, 2012
- Content source: